Related Experiment Video
Updated: Mar 5, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Rationale for Cardio-Oncology Units
Lara F Nhola1, Hector R Villarraga1
1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.
Insights
Cardio-oncology addresses the cardiovascular needs of cancer patients and survivors. This specialty manages treatment side effects and improves patient outcomes through collaborative care.
Area of Science:
- Cardiology
- Oncology
- Cardio-oncology
Background:
- Increasing number of cancer survivors with cardiovascular disease.
- Need for specialized care for cancer patients with heart conditions.
- Awareness of cardiovascular toxicity from cancer therapies is crucial.
Purpose of the Study:
- Outline the impact of cancer therapies on cardiovascular health.
- Highlight the benefits of a multidisciplinary team approach.
- Describe clinical care delivery for patients with cancer and heart disease.
Main Methods:
- Review of current literature on cardio-oncology.
- Discussion of collaborative care models.
- Analysis of cardiovascular complications from cancer treatments.
Main Results:
- Cancer therapies significantly impact cardiovascular health.
- Multidisciplinary teams improve management of cardiovascular complications.
- Specialized cardio-oncology care is essential for optimal outcomes.
Conclusions:
- Cardio-oncology bridges cardiology and oncology.
- Collaboration is key to mitigating cardiovascular toxicity.
- A comprehensive plan improves care for cancer patients with heart disease.
Abstract:
With the rapidly rising number of patients surviving cancer, often in the setting of new or pre-existing cardiovascular disease and risk factors, a need has arisen for a specialty within the realm of cardiovascular care that can evaluate and manage these patients along with our colleagues in oncology and hematology. By the same token, all health care providers involved in the care of cancer patients with heart disease must be fully aware of the impact of adverse cardiovascular effects on the survival of these patients. Collaboration is required to mitigate the effect of cardiovascular toxicity associated with these necessary life-saving cancer therapies. The cardio-oncologist plays a pivotal role in bridging the 2 specialties, by creating a comprehensive plan to address the comorbidities as well as to provide guidance on the optimal choice of therapy. In this 3-part review, we will outline: a) the significant impact of cancer therapies on the cardiovascular health of patients with cancer and cancer survivors, b) the advantage of a multidisciplinary team in addressing these cardiovascular complications, and c) the delivery of clinical care to patients with cancer and heart disease.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease V: Interprofessional Care
Heart Failure VI: Adjunct Therapies

